Acute Assessment 2. Cardiovascular System Guidelines
Anticoagulation Guidance
BNSSG DOAC decision aid March 2020
BNSSG Summary of considerations when prescribing a DOAC
BNSSG Anticoagulation questions and answers July 2013
Changing Anticoagulants v53 (undergoing review/update, expected summer 2021)
NBT DOAC counselling checklist (undergoing review/update, expected summer 2021)
NICE KTT16 Anticoagulants including DOACs
UHB Anticoagulants counselling
Please see BNSSG COVID-19: Coagulopathy, Thrombosis prevention and DIC
Anticoagulation Patient Information Leaflets (update re links and patient resources expected by July 2021)
Anticoagulation in AF
Apixaban- A Guide for patients with Atrial Fibrillation
Dabigatran- A guide for patients with Atrial Fibrillation
Rivaroxaban- A Guide for patients with Atrial Fibrillation
Antiplatelet Guidance
Antiplatelet Guidelines March 2021 BNSSG
Statin Guidance
BNSSG Management of Blood Lipid Levels (Statin Guidelines) 2020
AAC/NHSE Statin Intolerance Pathway
Heart Failure Guidance
Primary Care Heart Failure Treatment Guideline
Practical Guidance on how to use Heart Failure Medications
Traffic light: How to monitor renal function and potassium rises in stable Heart Failure
Use of Dapagliflozin (SGLT2i) in Patients with Heart Failure with Reduced Ejection Fraction
Raynaud's Phenomenon
Due to significant disruption with the supply of a number of Nifedipine preparations, see local advice document on alternative options for the management of Raynaud's Phenomenon, available here
Medical Management of Raynauds Phenomenon in view of Nifedipine supply changes (Nov 19).pdf